GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Nexen, Inc. (NXY) [hlAlert]

Rating:
Overweight
NXY
up 66.02 %

Nexen, Inc. (NXY) rated Overweight with price target $21 by Barclays Capital

Posted on: Wednesday,  Nov 30, 2011  1:25 PM ET by Barclays Capital

Barclays Capital rated Overweight Nexen, Inc. (NYSE: NXY) on 11/30/2011, when the stock price was $16.51. Since
then, Nexen, Inc. has gained 66.02% as of 02/25/2016's recent price of $27.41.
If you would have followed this Barclays Capital's recommendation on NXY, you would have gained 66.02% of your investment in 1548 days.

Nexen Inc. (Nexen) is an independent, Canadian-based, global energy company. Nexen operates in four segments: oil and gas, syncrude, energy marketing and chemicals. The Company owns 7.23% of the Syncrude Joint Venture. Energy marketing includes its crude oil, natural gas, natural gas liquids and power marketing business in North America, Europe and Asia. Chemicals include operations in North America and Brazil that manufacture, market and distribute sodium chlorate, caustic soda and chlorine through the Canexus Limited Partnership. Nexen has oil and gas operations in the United Kingdom North Sea, United States Gulf of Mexico, Yemen and other international (Colombia, offshore West Africa and Norway). Nexen has a 7.23% participating interest in Syncrude. The Company?s marketing group sells third-party natural gas, crude oil, natural gas liquids and power in certain regional global markets. Nexen manufactures sodium chlorate and chlor-alkali products in Canada and Brazil.

Barclays Capital has assembled a world-class, award-winning team of analysts covering, credit, commodities, economics, emerging markets, equities, fixed income, foreign exchange and market strategy. We provide in-depth analysis of companies and macro coverage across asset classes, markets and the world’s economies. We have a highly quantitative approach and our research is underpinned by sophisticated analytics. Combined, these provide clients with the tools and insights necessary for successful risk management and financing. Our research teams are based in many of the world’s major financial centres providing our clients with a globally integrated perspective across products and geographies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/30/2011 1:25 PM Buy
None
16.51 21.00
as of 12/30/2011
1 Week up  1.79 %
1 Month down  -3.98 %
3 Months up  2.71 %
1 YTD down  -30.52 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/16/2010 12:25 PM Buy
None
20.44 25.00
1/20/2010 8:25 AM Buy
None
22.69
7/13/2009 5:25 PM None
None
20.07 25.00
1/6/2009 8:25 AM None
None
19.59
11/26/2008 9:25 AM Buy
None
15.97 24.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy